Table 1.

Patient characteristics

Total patients	160
Primary site
Lung	8 (5%)
Pancreas	68 (43%)
Small bowel	40 (25%)
Other or unknown	44 (28%)
Degree of differentiation / grade
Well differentiated, low grade	99 (62%)
Well differentiated, intermediate to high grade; or moderately differentiated	46 (29%)
Poorly differentiated or undifferentiated	7 (4%)
Unknown	8 (5%)
Charlson comorbidity index (age adjusted)	6.4
Child Pugh score	5.2
ECOG performance status
0	144 (90%)
1	14 (9%)
2	2 (1%)
< 100 μm particles used	77 (48%)
Arteriovenous shunt on angiography	4 (3%)
Particle embolization of extrahepatic vessel at initial treatment	9 (6%)
Extrahepatic disease	127 (79%)
Disease volume ≥50% of liver	59 (37%)
Degree of selectivity
Lobar	126 (79%)
Selective	34 (21%)
Symptomatic or functional NET	77 (48%)
Urgent inpatient treatment	4 (3%)
Additional therapy
Radioembolization	4 (3%)
Ablation	2 (1%)
Liver resection	20 (13%)
Primary resection	43 (27%)
PRRT	18 (11%)
Somatostatin analogue	58 (36%)
Everolimus	21 (13%)
Sunitinib	7 (4%)
Cytotoxic chemotherapy	29 (18%)